AudioMedica News Bevacizumab: New Standard for Non-Small Cell Lung Cancer? Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast...

Oncology

Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

October 16, 2007

Jose Baselga Gordon McVie REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 JOSE BASELGA, Vall...

AJO ASCO Oncology

ASCO Audio Journal of Oncology in Advance -July 1st, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007

July 1, 2007

Christian Manegold Roy Herbst More Support for Bevacizumab in Advanced Lung Cancer REFERENCE: Abstract LBA7514, ASCO Annual Meeting Chicago June 1-5...

ASCO Oncology

Audio Journal of Oncology in Advance – November 1st, 2006

November 1, 2006

David Cameron Martine Piccart Eric Van Cutsem Jim Cassidy Volker Heinemann Lapatinib Better for Patients with HER2+ Refractory Breast Cancer Pre...

Tagbevacizumab

Audio Journal of Oncology Volume 16 Number 11

Audio Journal of Oncology Volume 16 Number 10

Audio Journal of Oncology Volume 16 Number 8

Bevacizumab: New Standard for Non-Small Cell Lung Cancer?

Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

ASCO Audio Journal of Oncology in Advance -July 1st, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007

Audio Journal of Oncology in Advance – November 1st, 2006

Menu

Sign up for AudioMedica.com news